Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco De Logu

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
British Journal of Pharmacology|May 21, 2024
Schwann cell TRPA1 elicits reserpine-induced fibromyalgia pain in miceEvelyne Silva Brum, Maria Fernanda Pessano Fialho, Daniel Souza Monteiro de Araújo, et al.
British Journal of Pharmacology|September 10, 2024
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microgliaLaura Latini, Daniel Souza Monteiro De Araujo, Rosario Amato, et al.
British Journal of Pharmacology|July 21, 2025
Anti-nociceptive action of leonurine through TRPA1 and TRPV4 channels modulationMatilde Marini, Lorenzo Landini, Elisabetta Coppi, et al.
Nature Communications|November 25, 2024
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosisMustafa Titiz, Lorenzo Landini, Daniel Souza Monteiro de Araujo, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
The density and spatial tissue distribution of CD8<sup>+</sup> and CD163<sup>+</sup> immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsDaniela Massi, Eliana Rulli, Mara Cossa, et al.
Brain : a Journal of Neurology|August 17, 2025
Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis modelPatrícia Rodrigues, Julia Maria Frare, Náthaly Andrighetto Ruviaro, et al.
British Journal of Pharmacology|February 16, 2026
Chikungunya virus-induced persistent allodynia is accompanied by joint microenvironmental changes and involves cartilage degradation and TRPA1 activationLiziane C M da Silva, Andressa C Dos Santos Maia, Nágila C F de Sousa, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
British Journal of Pharmacology|May 21, 2024
Schwann cell TRPA1 elicits reserpine-induced fibromyalgia pain in miceEvelyne Silva Brum, Maria Fernanda Pessano Fialho, Daniel Souza Monteiro de Araújo, et al.
British Journal of Pharmacology|September 10, 2024
A p75 neurotrophin receptor-sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microgliaLaura Latini, Daniel Souza Monteiro De Araujo, Rosario Amato, et al.
British Journal of Pharmacology|July 21, 2025
Anti-nociceptive action of leonurine through TRPA1 and TRPV4 channels modulationMatilde Marini, Lorenzo Landini, Elisabetta Coppi, et al.
Nature Communications|November 25, 2024
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosisMustafa Titiz, Lorenzo Landini, Daniel Souza Monteiro de Araujo, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
The density and spatial tissue distribution of CD8<sup>+</sup> and CD163<sup>+</sup> immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsDaniela Massi, Eliana Rulli, Mara Cossa, et al.
Brain : a Journal of Neurology|August 17, 2025
Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis modelPatrícia Rodrigues, Julia Maria Frare, Náthaly Andrighetto Ruviaro, et al.
British Journal of Pharmacology|February 16, 2026
Chikungunya virus-induced persistent allodynia is accompanied by joint microenvironmental changes and involves cartilage degradation and TRPA1 activationLiziane C M da Silva, Andressa C Dos Santos Maia, Nágila C F de Sousa, et al.
Pageof 10